Juvenescence US Corp. 3
3 · AgeX Therapeutics, Inc. · Filed Mar 22, 2023
Insider Transaction Report
Form 3
Juvenescence US Corp.
Director10% Owner
Holdings
- 16,447,500
Common Stock
Footnotes (1)
- [F1]Shares acquired pursuant to a transfer of securities from the reporting person's sole stockholder, Juvenescence Limited.